Effects of antidepressant and antipsychotic use on weight gain: a systematic review

L Alonso‐Pedrero, M Bes‐Rastrollo, A Marti - Obesity Reviews, 2019 - Wiley Online Library
Weight gain is an adverse effect of antidepressants and antipsychotics. This side effect can
lead to numerous comorbidities and reduces life expectancy. The use of these drugs is …

[HTML][HTML] Preclinical and clinical sex differences in antipsychotic-induced metabolic disturbances: a narrative review of adiposity and glucose metabolism

LN Castellani, KA Costa-Dookhan… - Journal of psychiatry …, 2019 - ncbi.nlm.nih.gov
Antipsychotic (AP) medications are associated with an increased risk of developing
metabolic side effects including weight gain, type 2 diabetes (T2D), dyslipidemia, and …

Sex differences in the association of body mass index with symptoms and cognitive deficits in Chinese patients with chronic schizophrenia

CW Wei, YQ Chen, M Ma, MH Xiu, XY Zhang - Translational psychiatry, 2020 - nature.com
Accumulating studies have revealed gender differences in many aspects of schizophrenia
(SZ), including obesity and cognitive function. The relationship between obesity and …

[HTML][HTML] Estrogens prevent the hypothalamus-periphery crosstalk induced by olanzapine intraperitoneal treatment in female mice: Effects on brown/beige adipose …

V Ferreira, C Folgueira, Á Montes-San Lorenzo… - … et Biophysica Acta (BBA …, 2024 - Elsevier
Olanzapine (OLA) is a highly obesogenic second-generation antipsychotic (SGA). Recently
we demonstrated that, contrarily to OLA oral treatment, intraperitoneal (ip) administration …

Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS)

E Stamoula, VP Stamatellos, T Vavilis… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Side effects are a very important aspect of antipsychotic treatments. Weight gain
is an important side effect that jeopardizes the uninterrupted therapy administration …

Weight gain is not associated with antipsychotic medication, sociodemographic factors, or diagnosis in a Welsh secure mental health unit

JL Davies, A Watt, R Bagshaw, C Hill… - International Journal of …, 2024 - Taylor & Francis
Many people treated in secure inpatient services have a serious mental illness and are
obese. This study aimed to assess the predictive power of demographic, clinical and …

Predictors of weight gain and metabolic indexes among men admitted to forensic psychiatric hospital

NZ Hilton, E Ham, S Hill, T Emmanuel… - … Journal of Forensic …, 2022 - Taylor & Francis
People with mental health disorders face elevated risk of metabolic syndrome (MetS), which
increases the risk of serious health problems and premature mortality. Obesity is prevalent …

Prevalence of underweight in people with severe mental illness: Systematic review and meta‐analysis

BA Khan, H Khalid, N Siddiqi, F Aslam… - Mental Health …, 2023 - Wiley Online Library
People with severe mental illness (SMI) have a higher prevalence of obesity as compared
with the general population, however, there is mixed evidence about the prevalence of …

A cross-continental analysis of weight gain, psychiatric diagnoses and medication use during inpatient psychiatric treatment. The international study on physical …

C Engelke, C Lange-Asschenfeldt, S Peter… - European …, 2018 - cambridge.org
Weight gain among psychiatric inpatients is a widespread phenomenon. This change in
body mass index (BMI) can be caused by several factors. Based on recent research, we …

Meta-analysis of genomic variants and gene expression data in schizophrenia suggests the potential need for adjunctive therapeutic interventions for neuropsychiatric …

SA Chellappa, AK Pathak, P Sinha, AK Jainarayanan… - Journal of genetics, 2019 - Springer
Schizophrenia (SZ) is a debilitating mental illness with a multigenic aetiology and significant
heritability. Despite extensive genetic studies, the molecular aetiology has remained …